Ethical frameworks in clinical research processes during COVID-19: a scoping review

Objectives In response to the COVID-19 pandemic there have been significant developments in research, its conduct and the supporting ethical framework. While many protocols have been delayed, halted or modified, other research efforts have been accelerated, generating controversy. The goal of this p...

Full description

Bibliographic Details
Main Authors: Amit M Oza, Qin Liu, Ainhoa Madariaga, Lawrence Kasherman, Lisa Wang, Michelle McMullen, Katherine Karakasis, Luisa Bonilla, Shiru (Lucy) Liu, Rouhi Fazelzad, Ann M Heesters
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/7/e047076.full
id doaj-e3c91c157690489db6792a5db944016d
record_format Article
spelling doaj-e3c91c157690489db6792a5db944016d2021-08-07T16:33:32ZengBMJ Publishing GroupBMJ Open2044-60552021-07-0111710.1136/bmjopen-2020-047076Ethical frameworks in clinical research processes during COVID-19: a scoping reviewAmit M Oza0Qin Liu1Ainhoa Madariaga2Lawrence Kasherman3Lisa Wang4Michelle McMullen5Katherine Karakasis6Luisa Bonilla7Shiru (Lucy) Liu8Rouhi Fazelzad9Ann M Heesters10Division of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaUniversity of Toronto, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaUniversity of Toronto, Toronto, Ontario, CanadaObjectives In response to the COVID-19 pandemic there have been significant developments in research, its conduct and the supporting ethical framework. While many protocols have been delayed, halted or modified, other research efforts have been accelerated, generating controversy. The goal of this paper is to determine the rates of references surrounding the ethical oversight of research as reported in current COVID-19-related research publications.Design Scoping review.Setting Population-based observational or interventional studies from December 2019 to May 2020 with sample size of two or more. Studies were searched through electronic databases including Medline, EMBASE, and Cochrane CENTRAL Register of Controlled Trials.Participants Eligibility criteria included participants within published studies who tested positive for COVID-19.Main outcomes and measures Data were extracted and charting methods included taking note of references to ethical frameworks, institutional review board (IRB), ethics committee (EC) or research ethics board (REB) involvement, consent processes, and other variables.Results 11 556 articles were screened, with 656 included in the final analysis. References to ethics were present in 530 (80.8%) studies, with 491 (74.8%) involving IRB/ECs/REBs and 126 (19.2%) not referencing ethics. Consent processes were outlined in 201 (30.6%) studies, with 198 (30.2%) reporting that they obtained consent waivers, however, 257 (39.2%) did not mention consent at all. Differences (p<0.001) in ethics-related references were apparent when analysed by continent, publication type, sample size and IF.Conclusions The majority of published articles pertaining to COVID-19 research made mention of ethical considerations, however, national and regional variations in research ethics review requirements introduce heterogeneity between studies and raise important questions about the conduct of scientific research during global public emergencies.Trial registration number Open Science Framework: https://osfio/z67wb.https://bmjopen.bmj.com/content/11/7/e047076.full
collection DOAJ
language English
format Article
sources DOAJ
author Amit M Oza
Qin Liu
Ainhoa Madariaga
Lawrence Kasherman
Lisa Wang
Michelle McMullen
Katherine Karakasis
Luisa Bonilla
Shiru (Lucy) Liu
Rouhi Fazelzad
Ann M Heesters
spellingShingle Amit M Oza
Qin Liu
Ainhoa Madariaga
Lawrence Kasherman
Lisa Wang
Michelle McMullen
Katherine Karakasis
Luisa Bonilla
Shiru (Lucy) Liu
Rouhi Fazelzad
Ann M Heesters
Ethical frameworks in clinical research processes during COVID-19: a scoping review
BMJ Open
author_facet Amit M Oza
Qin Liu
Ainhoa Madariaga
Lawrence Kasherman
Lisa Wang
Michelle McMullen
Katherine Karakasis
Luisa Bonilla
Shiru (Lucy) Liu
Rouhi Fazelzad
Ann M Heesters
author_sort Amit M Oza
title Ethical frameworks in clinical research processes during COVID-19: a scoping review
title_short Ethical frameworks in clinical research processes during COVID-19: a scoping review
title_full Ethical frameworks in clinical research processes during COVID-19: a scoping review
title_fullStr Ethical frameworks in clinical research processes during COVID-19: a scoping review
title_full_unstemmed Ethical frameworks in clinical research processes during COVID-19: a scoping review
title_sort ethical frameworks in clinical research processes during covid-19: a scoping review
publisher BMJ Publishing Group
series BMJ Open
issn 2044-6055
publishDate 2021-07-01
description Objectives In response to the COVID-19 pandemic there have been significant developments in research, its conduct and the supporting ethical framework. While many protocols have been delayed, halted or modified, other research efforts have been accelerated, generating controversy. The goal of this paper is to determine the rates of references surrounding the ethical oversight of research as reported in current COVID-19-related research publications.Design Scoping review.Setting Population-based observational or interventional studies from December 2019 to May 2020 with sample size of two or more. Studies were searched through electronic databases including Medline, EMBASE, and Cochrane CENTRAL Register of Controlled Trials.Participants Eligibility criteria included participants within published studies who tested positive for COVID-19.Main outcomes and measures Data were extracted and charting methods included taking note of references to ethical frameworks, institutional review board (IRB), ethics committee (EC) or research ethics board (REB) involvement, consent processes, and other variables.Results 11 556 articles were screened, with 656 included in the final analysis. References to ethics were present in 530 (80.8%) studies, with 491 (74.8%) involving IRB/ECs/REBs and 126 (19.2%) not referencing ethics. Consent processes were outlined in 201 (30.6%) studies, with 198 (30.2%) reporting that they obtained consent waivers, however, 257 (39.2%) did not mention consent at all. Differences (p<0.001) in ethics-related references were apparent when analysed by continent, publication type, sample size and IF.Conclusions The majority of published articles pertaining to COVID-19 research made mention of ethical considerations, however, national and regional variations in research ethics review requirements introduce heterogeneity between studies and raise important questions about the conduct of scientific research during global public emergencies.Trial registration number Open Science Framework: https://osfio/z67wb.
url https://bmjopen.bmj.com/content/11/7/e047076.full
work_keys_str_mv AT amitmoza ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT qinliu ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT ainhoamadariaga ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT lawrencekasherman ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT lisawang ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT michellemcmullen ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT katherinekarakasis ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT luisabonilla ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT shirulucyliu ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT rouhifazelzad ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT annmheesters ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
_version_ 1721217000707981312